Tumor microenvironment governs various therapeutic tolerability of cancer such as ferroptosis and immunotherapy through rewiring tumor metabolic reprogramming like Warburg metabolism. Highly expressed carbonic anhydrases (CA) in tumor that maintaining the delicate metabolic homeostasis is thus the most potential target to be modulated to resolve the therapeutic tolerability. Hence, in this article, a self-healable and pH-responsive spermidine/ferrous ion hydrogel loaded with CA inhibitor (acetazolamide, ACZ) and glucose oxidase (ACZ/GOx@SPM-HA Gel) was fabricated through the Schiff-base reaction between spermidine-dextran and oxidized hyaluronic acid, along with ferrous coordination. Investigation on cancer cell lines (MOC-1) demonstrated ACZ/GOx@SPM-HA Gel may induce cellular oxidative stress and mitochondrial dysfunction through disrupting the cellular homeostasis. Moreover, with the facilitation of autophagy induced by spermidine, ACZ/GOx@SPM-HA Gel may trigger a positive feedback loop to maximally amplify cellular ferroptosis and promote DAMPs release. The anti-tumor evaluation on xenograft mice models furtherly proved the local injection of such hydrogel formulation could efficiently inhibit the tumor growth and distinctively promote the immunogenicity of tumor bed to provide a more favorable environment for immunotherapy. Overall, ACZ/GOx@SPM-HA Gel, with such feasible physiochemical properties and great biocompatibility, holds great potential in treating solid tumors with acidosis-mediated immunotherapy tolerance.
Mitochondrial dysfunction and oxidative stress are key contributors to age-related hearing loss (ARHL). Sestrin2, a stress-inducible antioxidant protein, decreases with age, impacting various age-related diseases; however, its role in ARHL remains unclear. In this study, we initially assessed hearing in 8-week-old mice, followed by adeno-associated virus-mediated transfection of Sestrin2 into the posterior semicircular canal. At 26 weeks, hearing was reassessed, and cochlear samples were analysed. Immunofluorescence staining revealed Sestrin2 localization and mitophagy marker PINK1 expression, and TUNEL staining was used to assess hair cell apoptosis rate. We also measured mitochondrial membrane potential and examined AMPKα, mTOR, PINK1, Parkin, and Sestrin2 protein levels. Results showed reduced Sestrin2 in ARHL-affected hair cells, leading to mitochondrial dysfunction and increased apoptosis. Sestrin2 overexpression enhanced mitochondrial membrane potential, ATP levels, and mitochondrial function, delaying hair cell ageing and apoptosis and improving hearing. Furthermore, AMPK activation inhibited mTOR to promote mitophagy as the cells aged, whereas Sestrin2 overexpression inhibited this pathway, directly protecting hair cells. These findings highlight Sestrin2’s critical role in auditory health and its potential as a therapeutic target for delaying ARHL.
Sinonasal inverted papilloma (SNIP) is less malignant and usually occur in the maxillary sinus. However, cases invading the pterygopalatine fossa are extremely rare. In this article, we describe a rare case of a man in his early 60s who presented with left nasal congestion, headache, epistaxis, and facial numbness. The patient underwent a comprehensive treatment primarily based on surgery. Nasal endoscopy showed that the mass had invaded the left infratemporal fossa laterally and was poorly separated from the internal maxillary artery, which increased the complexity and difficulty of the surgery. In addition, the patient had previously undergone nasal cavity surgery, which made the surgery more challenging. In order to reduce the risk of recurrence, we exposed the infratemporal fossa region under nasal endoscopic guidance with a combined labial and gingival incision, and completely removed the tumor base and tumor margins. There were no postoperative complications and no recurrence was observed during the 2-year follow-up period.